HomeIMRX • NASDAQ
add
Immuneering Corp
Previous close
$2.11
Day range
$2.06 - $2.25
Year range
$1.00 - $8.89
Market cap
62.27M USD
Avg Volume
1.30M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 15.27M | 9.68% |
Net income | -14.60M | -15.90% |
Net profit margin | — | — |
Earnings per share | -0.49 | -13.95% |
EBITDA | -15.18M | -9.66% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 50.66M | -47.91% |
Total assets | 68.56M | -39.80% |
Total liabilities | 10.84M | 9.86% |
Total equity | 57.72M | — |
Shares outstanding | 31.05M | — |
Price to book | 1.13 | — |
Return on assets | -52.43% | — |
Return on capital | -57.60% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -14.60M | -15.90% |
Cash from operations | -13.47M | -12.02% |
Cash from investing | -5.42M | 77.41% |
Cash from financing | 4.36M | 20,249.61% |
Net change in cash | -14.52M | 59.63% |
Free cash flow | -9.97M | -27.21% |
About
Founded
2008
Website
Employees
66
